<VariationArchive RecordType="classified" VariationID="1068994" VariationName="NC_000017.10:g.(?_48243138)_48245027del" VariationType="Deletion" Accession="VCV001068994" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2021-12-02" MostRecentSubmission="2021-12-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1057971" VariationID="1068994">
      <GeneList>
        <Gene Symbol="SGCA" FullName="sarcoglycan alpha" GeneID="6442" HGNC_ID="HGNC:10805" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>17q21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50166005" stop="50175928" display_start="50166005" display_stop="50175928" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48243365" stop="48253292" display_start="48243365" display_stop="48253292" Strand="+" />
          </Location>
          <OMIM>600119</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000017.10:g.(?_48243138)_48245027del</Name>
      <VariantType>Deletion</VariantType>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.(?_48243138_48245027del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.(?_48243138_48245027del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.(?_48243138)_48245027del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.(?_48243138)_48245027del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000017.10:g.(?_48243138)_48245027del AND Autosomal recessive limb-girdle muscular dystrophy type 2D" Accession="RCV001380701" Version="2">
        <ClassifiedConditionList TraitSetID="2593">
          <ClassifiedCondition DB="MedGen" ID="C2936332">Autosomal recessive limb-girdle muscular dystrophy type 2D</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-09-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-12-02" MostRecentSubmission="2021-12-02">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9192266</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2593" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3065" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ADHALINOPATHY, PRIMARY</ElementValue>
                <XRef Type="MIM" ID="608099" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2D</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2D/4239" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy limb-girdle with alpha-sarcoglycan</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Duchenne-like autosomal recessive muscular dystrophy, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3</ElementValue>
                <XRef Type="MIM" ID="608099" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600119.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600119.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600119.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600119.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600119.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600119.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600119.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2D</ElementValue>
                <XRef ID="MONDO:0011968" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DMDA2</ElementValue>
                <XRef Type="MIM" ID="608099" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR3</ElementValue>
                <XRef Type="MIM" ID="608099" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="438" />
                <XRef ID="438" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism">Affects gamma-sarcoglycan and also disrupts the integrity of the entire sarcoglycan complex.</Attribute>
                <XRef ID="GTR000509473" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="62" DB="Orphanet" />
              <XRef ID="C2936332" DB="MedGen" />
              <XRef ID="MONDO:0011968" DB="MONDO" />
              <XRef Type="MIM" ID="608099" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3104434" SubmissionDate="2021-11-23" DateLastUpdated="2021-12-02" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_000023.2_17_Deletion (exons 1-3)_48243137_48245027|MedGen:C2936332" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001578831" DateUpdated="2021-12-02" DateCreated="2021-05-10" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9192266</ID>
          </Citation>
          <Comment>This variant results in the deletion of exons 1-2 and part of exon 3 (c.-261_245del) of the SGCA gene. This is expected to result in an absent or disrupted protein product. This variant has been observed in individual(s) with clinical features of muscular dystrophy (Invitae). Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.(?_48243138)_48245027del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2936332" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8755776</SubmissionName>
          <SubmissionName>SUB10689444</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3104434" TraitType="Disease" MappingType="XRef" MappingValue="C2936332" MappingRef="MedGen">
        <MedGen CUI="C2936332" Name="Autosomal recessive limb-girdle muscular dystrophy type 2D" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

